Type 2 Diabetes|Journals Open Access|Type 2 Diabetes

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Type 2 Diabetes

"Type 2 diabetes (T2D) is a chronic metabolic disorder characterized by abnormalities of glucose homeostasis by various organs. It accounts for about 85-95% of all diagnosed cases of diabetes and is associatedwith considerable morbidity and mortality Several treatment strategies are being adopted to ameliorate T2D by therapeutic intervention. Synthetic drugs, despite having excellentpotencies, had offered unwanted therapeutic profiles marked by fluid retention, drug-induced hypoglycemia, liver malfunctioning, weightgain and cardiac dysfunction. Thus, there is a lot of scope for herbal medicines which have emerged as safe and relatively economicalalternative therapy found to be effective as add on therapy, in the long- term management of type 2 diabetes. OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals with the support of 50,000+ editorial board members as editorial team and aimed to disseminate the scholarly knowledge to the scientific society. OMICS Group also organizing 3000+ International Scientific Conferences and events yearly all over the world with the support of 1000+ Scientific associations worldwide. Citation: Bharti SK, Kumar A, Prakash O, Krishnan S, Gupta AK (2013) Essential Oil of Cymbopogon Citratus Against Diabetes: Validation by In vivo Experiments and Computational Studies. J Bioanal Biomed 5: 194-203."
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on August, 2021